4100DX stands at the forefront of health innovation and patient capital, uniquely merging long-term investment with transformative healthcare advancements. Our mission is to reshape health and wellness by making strategic investments in care delivery, therapeutics and state-of-the-art medical and dental technologies. Propelled by a seasoned team of experts, the collective vision and expertise at 4100DX shapes the healthcare and oral care ecosystems through our precision-oriented approach.
From seed-stage ventures to strategic buyouts, we leverage our expertise to provide financial backing to innovative startups and established companies alike. We fuel their growth and facilitate the development of groundbreaking health-related products and other advancements aimed at improving global wellness.
Our investable capital base—established through both permanent capital vehicles and more traditional funds—enables us to forge enduring partnerships with visionary leaders in the industry. Together, we redefine categories, cultivate exceptional companies, and drive the development of uniquely innovative products.
Our investments directly impact the quadruple aim and represent a balance of clinical, economic and humanistic factors in the interest of creating both immediate and future shared value. We help the builders of the future rethink how sustained value creation can come about through insight, foresight and cross-sight into the converging megatrends of predictive, personalized, preventative and participatory 21st century models of care.
Powered by patient capital, we propel the advancement of computationally-advanced platforms for drug discovery, optimization, repurposing, and delivery. Our investment in innovative hardware and software solutions fuels progress in precision medicine, diagnostics, and targeted treatments, ushering in an era of personalized and effective care for all.
Investing in innovative health tech and life science companies, we bridge the gap between traditional medical and dental care in the pursuit of sustained growth and improved patient outcomes. Acknowledging the intricate relationship between oral health and overall well-being—and in response to the rising demand for integrated healthcare solutions—we are steadfast in our commitment to expanding access, reducing costs, and enhancing the healthspan of individuals.
Our initial venture investments spanned healthcare and life sciences, encompassing digital health, medical devices and diagnostics, biotech, Pharma, and analytics. With three successful exits in just 13 months, we actively guide and support our portfolio companies through subsequent funding rounds. This fund catalyzed the development of the P9 framework, a robust analytical tool that underpins our investment decision-making process.
